CLEPSO Meeting 2018 - Program

Clinical Epigenetics International Meeting

Thursday March 8th – Friday March 9th, 2018

Düsseldorf, Germany


Day one, March 8th, 2018

Get together 9:30 h – 10:00 h



Ulrich Mahlknecht, Conference Organizer


Keynote Speakers


Session Chairs: n.n. 


10:00 h – 10:30 h Kirsten Grønbæk, Copenhagen Biocenter, Copenhagen, Denmark

Modulation of the Immune System by Epigenetic Therapy


10:30 h – 11:00 h Arpad PATAI, Semmelweis University, Budapest, Hungary

Clinical Implications of DNA Methylation in Inflammatory Bowel Disease, Colorectal Polyps and Cancer


11:00 h – 11:30 h Jim DAVIE, University of Manitoba, Winnipeg, Canada

Epigenetic Profiling of Fetal Alcohol Syndrome and Type II Diabetes


11:30 h – 12:00 h Janos MINAROWITS, University of Szeged, Szeged, Hungary

Epigenetic Dysregulation Through Infectious Disease


Lunch break 12:00 h – 13:00 h


Session Chairs: n.n


13:00 h – 13:30 h Henk STUNNENBERG, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands 

The Interplay of Epigenetic Marks During Stem Cell Differentiation and Development.


13:30 h – 14:00 h Christian HEDRICH, University of Liverpool, Liverpool, UK

On the Epigenetics of Systemic Lupus Erythematosus 


14:00 - 14:30 h Fabio COPPEDÈ, University of Pisa, Pisa, Italy

Pharmacoepigenetics and Pharmacoepigenomics of Gastrointestinal Cancers  


14:30 h – 15:00 h Pamela MUNSTER, University of California, San Francisco CA, USA

Select HDAC Enzyme Expression as Host Specific Biomarkers


Coffee break 15:00 h – 15:30 h

Session Chairs: n.n.


15:30 h – 16:00 h Gerd PFEIFER, Cancer for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA

Oxidation of 5-Methylcytosine in Development and Disease


16:00 h – 16:30 h Jesper Boje ANDERSEN, Univesity of Copenhagen, Copenhagen, Denmark 

Epigenetics of Cholangiocarcinoma


16:30 h – 17:00 h Charlotte LING, University of Lund, Malmö, Sweden

The Effects of High Glucose Exposure on Global Gene Expression and DNA Methylation in Human Pancreatic Islets.


20:00 Dinner






Day two, March 9th, 2018


Session Chairs: n.nn


9:00 h – 9:30 h Vim Van Den BERGHE, University of Antwerp, Belgium

BRCA Methylation Changes in Cancer and Cardiovascular Disease


9:30 h – 10:00 h David S. SCHRUMP, NIH, Bethesda, MD, USA

Epigenetics of Malignant Pleural Mesothelioma


10:00 h – 10:30 h Bart P.F. RUTTEN, Maastricht University Medical Centre, Maastricht, the Netherlands

The Epigenetics of Aging and Neurodegeneration


Coffee break 10:30 h – 11:00 h


Session Chairs: n.n.


11:00 h – 11:30 h Lucia ALTUCCI, University of Naples, Naples, Italy

From Single-Target to Multi-Target Epigenetic Therapeutics


11:30 h – 12:00 h Sam KEATING, Radboud Center for Infectious Diseases, Nijmegen, The Netherlands

Epigenetics and the Immune System


Lunch break 12:00 h – 13:00 h


Session Chairs: n.n.


13:00 h – 13:30 h Edyta RESZKA, Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Diseases, Lodz, Poland

Circadian Gene Variants and Breast Cancer.


13:30 h – 14:00 h Vessela N. KRISTENSEN, University of Oslo, Oslo, Norway

DNA Methylation at Enhancers Identifies Distinct Breast Cancer Lineages.


14:00 h – 14:30 h Anton SHOSTAK, University of Heidelberg, Heidelberg, Germany

Circadian Clock, Cell Division, and Cancer: From Molecules to Organism.


Coffee break 14:30 h – 15:00 h


Session Chairs: n.n.


15:00 h – 15:30 h James D. FLANAGAN, Imperial College of London, London, UK

Epigenome-Wide Association Studies for Breast Cancer Risk and Risk Factors.


15:30 h – 16:00 h Alessio SQUASSINA, University of Cagliari, Cagliari, Italy

Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing Treatment


16:00 h – 16:30 h  Jonathan LICHT, University of Florida, Gainesville, FL, USA

Epigenetic Dysregulation in Lymphoid Malignancy


16:30 h Ulrich MAHLKNECHT

Concluding Remarks, End of Congress